Sulfadiazine Price Trend and Forecast

Sulfadiazine Regional Price Overview

Get the latest insights on price movement and trend analysis of Sulfadiazine meal in different regions across the world (Asia, Europe, North America, Latin America, and the Middle East & Africa).

Sulfadiazine Price Trend for Q1 of 2025

The global Sulfadiazine market exhibited diverse regional trends throughout the first quarter of 2025. While North American markets maintained relative stability, Asian and European markets displayed more pronounced fluctuations in response to regional industry dynamics.
 

Sulfadiazine Price Chart

Please Login or Subscribe to Access the Sulfadiazine Price Chart Data
 

North American supply remained consistent, with manufacturers operating at steady rates throughout the quarter. In contrast, Asian markets, particularly in China and India, experienced brief production constraints in February due to seasonal factory schedules and raw material availability issues. European producers maintained adequate output despite energy cost pressures early in the quarter.

Pharmaceutical demand drove consumption across all regions, with strongest performance in Western European markets where healthcare investments continued to expand. Asian markets saw increased veterinary applications, particularly in poultry and aquaculture sectors. North American consumption patterns remained balanced between pharmaceutical and agricultural applications.

Regional feedstock situations varied considerably, with Asian manufacturers facing greater volatility than their Western counterparts. Despite these variations, most producers successfully navigated input challenges through inventory management and procurement strategies.

Analyst Insight

According to Procurement Resource, the global Sulfadiazine market is expected to strengthen gradually heading into Q2, supported by seasonal increases in agricultural applications and consistent pharmaceutical demand, though regional differences will likely persist.
 

Sulfadiazine Price Trend for the Second Half of 2024

The Sulfadiazine market in the second half of 2024 showed distinct regional patterns across global markets. In Q3’24, North American Sulfadiazine prices remained stable amid moderate pharmaceutical demand. This stability was attributed to well-managed supply chains and consistent production capabilities despite some economic challenges. In contrast, the APAC region, with China leading the way, experienced gradual price increases throughout the quarter. This upward movement resulted from heightened buying interest, improved trading activities, and sustained demand from the pharmaceutical sector. European markets moved in the opposite direction, with prices easing slightly due to decreased feedstock costs, which created favorable production economics.

The fourth quarter showed a strengthening trend across all regions. North American Sulfadiazine prices firmed up, supported by robust production capacities, effective inventory management, and steady demand from biopharmaceutical activities. The APAC region, particularly South Korea, saw the most notable price strengthening, initially triggered by logistical disruptions and production delays before stabilizing later in the quarter. European markets experienced significant growth driven by expanding pharmaceutical applications, including active pharmaceutical ingredients and drug formulations.

Analyst Insight

According to Procurement Resource, the Sulfadiazine market appears headed for continued growth in the pharmaceutical sector, while regulatory changes and the increasing emphasis on sustainable production methods may reshape market dynamics in the coming year.
 

Sulfadiazine Price Trend for the First Half of 2024

The prices of Sulfadiazine remained stable in the first half of 2024. Though the price showed regional variations, the trend remained steady without any dramatic changes. Sulphadiazine, a sulfonamide antibiotic, is commonly used to treat bacterial infections in both humans and animals by inhibiting the synthesis of folic acid in bacteria, effectively stunting their growth and reproduction.

The antibiotic market is highly controlled in most countries in terms of prices and formulations, which makes them affordable and increases their availability. Due to this, the prices of sulphadiazine were found to be wavering in the confined limits. However, the incline in the production costs negatively affected the market. Most of the imported raw materials showed hikes in prices due to heightened freight rates and disruptions in global supply chains.

Apart from this, the growth of the pharmaceutical industry directly benefits the sale and sulphadiazine drugs. In recent months, several multinational pharmaceutical corporations have increasingly sought partnerships with Indian companies to enhance their market presence in India's pharmaceutical sector. This strategy enables these companies to utilize established local networks for broader audience reach while providing Indian firms access to global brands and expertise. A win-win situation for both MNCs and local firms. This will help in the formulation of effective and affordable drugs.

Analyst Insight

According to Procurement Resource, the prices of Sulfadiazine are expected to remain stable in the upcoming quarter as antibiotic markets are highly regulated markets. Much variation is not anticipated.
 

Sulfadiazine Price Trend for the Second Half of 2023

Sulfadiazine drugs or sulpha drugs are the sulfonamide class antibiotics commonly used for topical bacterial infections. The upstream and production-related costs of sulfadiazine drugs depend primarily on the market availability and prices of the feedstock sulfonyl chloride and aminopyridine compounds. However, since the pharma sector is a highly regulated and monitored sector, the market prices were largely found to be wavering within very confined limits.

The production costs, however, were observed to be inclined for the majority of said period. Since the increment in crude oil prices generally lifted the production costs for most products, the Sulfadiazine drugs also saw a rise in production costs in the third quarter. And the raw materials too maintained the positive momentum in the fourth quarter as well. Overall, general market sentiments were largely positive.

Analyst Insight

According to Procurement Resource, not much change is anticipated in the Sulfadiazine drug market going forward as well. The supply and demand dynamics look stable.
 

Sulfadiazine Price Trend for First Half of 2023

A class of pharmaceuticals called sulfadiazine, also known as sulfa drugs, is used to treat bacterial infections. They can be used as oral, topical, vaginal, or ophthalmic therapy and come in a variety of formulations.

The market activities of sulfadiazine were directly dependent on the performance of the pharmaceutical sector. In India, several steps were taken to boost the production activities of drugs and rise in the level of imports. The government policies promoted the import rates as it looked forward to mending the disrupted supply chains caused by the pandemic.

In addition to this, the dependence of India’s pharmaceutical sector on the influx of raw materials from other nations is also affecting the price trend of sulfadiazine. In the first and second quarters, the pharmaceutical sector surged as the production activities geared up, but the rise in the cost of imported raw materials is the major cause of the high uncertainties in the price trend of sulfadiazine.

Analyst Insight

According to Procurement Resource, Sulfadiazine price is estimated to showcase an oscillating trajectory as the Asian pharmaceutical sector is heavily dependent on the import of raw materials and functionality of the global pharmaceutical food chains.

Procurement Resource provides latest prices of Sulfadiazine. Each price database is tied to a user-friendly graphing tool dating back to 2014, which provides a range of functionalities: configuration of price series over user defined time period; comparison of product movements across countries; customisation of price currencies and unit; extraction of price data as excel files to be used offline.